Literature DB >> 25974139

Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study.

Yeonjung Ha1, Nieun Seo2, Ju Hyun Shim1, So Yeon Kim2, Jin-A Park1, Seungbong Han3, Kyoung Won Kim2, Eunsil Yu4, Kang Mo Kim1, Young-Suk Lim1, Han Chu Lee1, Young-Hwa Chung1, Yung Sang Lee1.   

Abstract

BACKGROUND AND AIM: To identify factors associated with non-alcoholic fatty liver disease (NAFLD) in healthy Asian subjects.
METHODS: A propensity score-matched case-control study was designed. To investigate the effects of demographic and clinical factors on the presence of NAFLD, a baseline-category logit model was used. Potential living liver donors with no hepatic steatosis (< 5%: n = 1353, group 1) were considered the baseline category, and subjects with mild (5-33%: n = 724, group 2) and moderate/severe (> 33%: n = 116, group 3) hepatic steatosis were defined as cases. Age and gender were matched between cases and controls, which resulted in 83 matched subjects in each of the three groups. The area of abdominal (visceral and subcutaneous) fat was directly measured in all subjects by unenhanced computed tomography.
RESULTS: Serum aspartate aminotransferase, alanine aminotransferase (ALT), gamma-glutamyltranspeptidase, total cholesterol and triglyceride levels, and visceral fat amount were directly correlated with the grade of hepatic steatosis, and high-density lipoprotein cholesterol levels were inversely correlated with it (all P values < 0.05). In a multivariate model, visceral fat amount was significantly correlated with both mild (group 2) and moderate to severe (group 3) NAFLD, with respective odds ratios (ORs) of 1.03 relative to group 1 (Ps < 0.05). Body mass index (BMI), ALT, and subcutaneous fat were significant predictors of only moderate to severe NAFLD (ORs of 0.54, 1.20, and 1.02, respectively, for group 3 vs group 1; Ps < 0.05).
CONCLUSIONS: Our results indicate that visceral adiposity makes non-obese subjects more susceptible to NAFLD, compared with subcutaneous fat and BMI.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  healthy Asian subjects; non-alcoholic fatty liver disease; visceral fat

Mesh:

Substances:

Year:  2015        PMID: 25974139     DOI: 10.1111/jgh.12996

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

Review 1.  Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective.

Authors:  Naga S Samji; Rajanshu Verma; Sanjaya K Satapathy
Journal:  J Clin Exp Hepatol       Date:  2019-05-16

2.  Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.

Authors:  Jin-Zhou Zhu; Hua-Tuo Zhu; Yi-Ning Dai; Chun-Xiao Li; Zhi-Yun Fang; De-Jian Zhao; Xing-Yong Wan; Yu-Ming Wang; Fang Wang; Chao-Hui Yu; You-Ming Li
Journal:  Endocrine       Date:  2015-09-11       Impact factor: 3.633

Review 3.  Dysregulated lipid storage and its relationship with insulin resistance and cardiovascular risk factors in non-obese Asian patients with type 2 diabetes.

Authors:  Chatchalit Rattarasarn
Journal:  Adipocyte       Date:  2018-02-07       Impact factor: 4.534

Review 4.  Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.

Authors:  Ramesh Kumar; Shantam Mohan
Journal:  J Clin Transl Hepatol       Date:  2017-07-05

5.  Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation.

Authors:  Ai-Hong Yu; Yang-Yang Duan-Mu; Yong Zhang; Ling Wang; Zhe Guo; Yong-Qiang Yu; Yu-Sheng Wang; Xiao-Guang Cheng
Journal:  Korean J Radiol       Date:  2018-08-06       Impact factor: 3.500

Review 6.  Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.

Authors:  Hamza El Hadi; Angelo Di Vincenzo; Roberto Vettor; Marco Rossato
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

7.  Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.

Authors:  Lampros Chrysavgis; Eleftheria Ztriva; Adonis Protopapas; Konstantinos Tziomalos; Evangelos Cholongitas
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

8.  Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.

Authors:  Chung-Hao Li; Yu-Tsung Chou; Wei-Chen Shen; Feng-Hwa Lu; Yi-Ching Yang; Jin-Shang Wu; Chih-Jen Chang
Journal:  J Diabetes Investig       Date:  2020-05-17       Impact factor: 4.232

9.  Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Marta Hernández-Conde; Elba Llop; Carlos Fernández Carrillo; Beatriz Tormo; Javier Abad; Luis Rodriguez; Christie Perelló; Marta López Gomez; José Luis Martínez-Porras; Natalia Fernández Puga; Maria Trapero-Marugan; Enrique Fraga; Carlos Ferre Aracil; José Luis Calleja Panero
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

10.  The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease.

Authors:  Jiang Deng; Yonghong Zhang; Limei Bu; Haitao Shi; Hailing Tang; Shenhao Wang; Qian Wang; Shuangsuo Dang; Ming Li; Zhiyi Han; Xiaolan Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-17       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.